Met Life Investment Management, LLC Immunic, Inc. Transaction History

Met Life Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.13 - $12.25 $37,178 - $145,505	-11,878 Closed	0 $0
Q1 2022 May 10, 2024	BUY	$9.54 - $14.26 $113,316 - $169,380	11,878 New	11,878 $134,000
Q1 2022 Jun 20, 2023	BUY	$9.54 - $14.26 $113,316 - $169,380	11,878 New	11,878 $134,000
Q1 2022 Mar 22, 2023	BUY	$9.54 - $14.26 $113,316 - $169,380	11,878 New	11,878 $134,000
Q1 2022 May 12, 2022	BUY	$9.54 - $14.26 $113,316 - $169,380	11,878 New	11,878 $134,000

49.5M

184K

307K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $30.6M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.